Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ELOVL6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NMRK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMLN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC400748 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FAM53A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCOA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DLL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIANP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928449 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGEF12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBMXL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNED1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPOCD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FSCN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CALD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITGAX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on